Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study also demonstrates evidence suggesting that the regulation of ITSN1-S on glioblastoma cells proliferation is through the Raf/MEK/ERK pathway.
|
25832561 |
2015 |
Alzheimer's Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
This study reveals a link between overexpression of specific ITSN1 isoforms and behavioral phenotypes and has implications for human neurodegenerative diseases such as Down's syndrome and Alzheimer's disease.
|
21876463 |
2011 |
Alzheimer's Disease
|
0.020 |
Biomarker
|
disease |
LHGDN |
This review discusses in detail the known and potential roles of ITSN1 and DSCR1 in DS, AD, endocytosis and vesicle trafficking.
|
16442855 |
2006 |
Androgen-Insensitivity Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
lnc-ITSN1-2 expression was increased in AIS patients compared to controls (P < .001), and receiver operating characteristic curve revealed its predictive value for AIS risk (area under the curve: 0.804, 95% confidence interval, 0.763-0.845).
|
31647141 |
2020 |
Arteriopathic disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.
|
28068512 |
2017 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
ONCOMINE, GEPIA, UALCAN, and Human Protein Atlas databases were used to investigate the characteristics of ITSN1 for the prognosis of breast carcinoma.
|
31564893 |
2019 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Orthotopic animal models can provide insight into the role of ITSN1 pathways in neuroblastoma tumorigenesis.
|
28787396 |
2017 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Besides its well-established role in endocytosis, ITSN1-s is involved in the regulation of cell signaling and is implicated in tumorigenesis processes, although the signaling pathways involved are still poorly understood.
|
29599122 |
2018 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Overexpression of the ITSN1 target, PI3K-C2β, rescues the soft agar growth of ITSN1-silenced cells demonstrating the importance of the ITSN1-PI3K-C2β pathway in neuroblastoma tumorigenesis.
|
22266851 |
2012 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
Restoring ITSN-1s deficiency in lung cancer cells facilitates cytoskeleton changes favoring mesenchymal to epithelial transformation and impairs lung cancer progression.
|
28874189 |
2017 |
Carcinoma of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Restoring ITSN-1s protein level decreases LC cell proliferation and clonogenic potential.
|
27629044 |
2016 |
Central neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
SK-N-AS neuroblastoma cells transfected with empty vector (pSR), vectors expressing scrambled shRNA (pSCR), or shRNAs targeting ITSN1 (sh#1 and sh#2) were used to create orthotopic neuroblastoma tumors in mice.
|
28787396 |
2017 |
Central neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Overexpression of the ITSN1 target, PI3K-C2β, rescues the soft agar growth of ITSN1-silenced cells demonstrating the importance of the ITSN1-PI3K-C2β pathway in neuroblastoma tumorigenesis.
|
22266851 |
2012 |
Central neuroblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We previously demonstrated that PI3K Class IIβ (PI3KC2β) and its regulator intersectin 1 (ITSN1) are highly expressed in primary NB tumors and cell lines.
|
25622909 |
2015 |
Childhood Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study also demonstrates evidence suggesting that the regulation of ITSN1-S on glioblastoma cells proliferation is through the Raf/MEK/ERK pathway.
|
25832561 |
2015 |
Childhood Neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Overexpression of the ITSN1 target, PI3K-C2β, rescues the soft agar growth of ITSN1-silenced cells demonstrating the importance of the ITSN1-PI3K-C2β pathway in neuroblastoma tumorigenesis.
|
22266851 |
2012 |
Childhood Neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
SK-N-AS neuroblastoma cells transfected with empty vector (pSR), vectors expressing scrambled shRNA (pSCR), or shRNAs targeting ITSN1 (sh#1 and sh#2) were used to create orthotopic neuroblastoma tumors in mice.
|
28787396 |
2017 |
Childhood Neuroblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We previously demonstrated that PI3K Class IIβ (PI3KC2β) and its regulator intersectin 1 (ITSN1) are highly expressed in primary NB tumors and cell lines.
|
25622909 |
2015 |
Chromosome 21 monosomy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Microcephaly and brain structural abnormalities including polymicrogyria and agenesis/hypoplasia of the corpus callosum may also result from haploinsufficiency of ITSN1, highlighting its clinical significance for the neurological features of patients with monosomy 21.
|
24458657 |
2014 |
Complete Trisomy 21 Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
This study reveals a link between overexpression of specific ITSN1 isoforms and behavioral phenotypes and has implications for human neurodegenerative diseases such as Down's syndrome and Alzheimer's disease.
|
21876463 |
2011 |
Complete Trisomy 21 Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
So fully understanding functions of intersectin 1 is critical for revealing the pathogenesis of DS.
|
19037327 |
2008 |
Congenital Abnormality
|
0.010 |
Biomarker
|
group |
BEFREE |
Knockout (KO) mice lacking ITSN1 suffer from dispersion of pyramidal neurons and malformation of the radial glial scaffold, akin to the hippocampal lamination defects observed in VLDLR or ApoER2 mutants.
|
28484035 |
2017 |
Coronary Artery Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study aimed to investigate the associations of circulating long, non-coding (lncRNA) IFNG-AS1, lncRNA ANRIL and lncRNA ITSN1 relative expressions with disease risk, severity and inflammatory cytokines levels in coronary artery disease (CAD) patients.
|
29744951 |
2018 |
Deformity
|
0.010 |
Biomarker
|
group |
BEFREE |
Knockout (KO) mice lacking ITSN1 suffer from dispersion of pyramidal neurons and malformation of the radial glial scaffold, akin to the hippocampal lamination defects observed in VLDLR or ApoER2 mutants.
|
28484035 |
2017 |